I. Fishbein

发表

Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles

R. Levy, H. Cohen, J. Gao, 2000, Gene Therapy.

Macrophage Depletion by Clodronate-Containing Liposomes Reduces Neointimal Formation After Balloon Injury in Rats and Rabbits

I. Fishbein, G. Golomb, H. Danenberg, 2002, Circulation.

Poloxamer‐linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high‐risk neuroblastoma with primary and acquired chemoresistance

I. Alferiev, I. Fishbein, G. Brodeur, 2022, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Real-time analysis of composite magnetic nanoparticle disassembly in vascular cells and biomimetic media

I. Alferiev, R. Levy, I. Fishbein, 2014, Proceedings of the National Academy of Sciences.

Metalloproteinase inhibitor attenuates neointima formation and constrictive remodeling after angioplasty in rats: augmentative effect of alpha(v)beta(3) receptor blockade.

I. Fishbein, G. Golomb, S. Banai, 2002, Atherosclerosis.

Metalloproteinase inhibitor attenuates neointima formation and constrictive remodeling after angioplasty in rats: augmentative effect of αvβ3 receptor blockade

I. Fishbein, G. Golomb, S. Banai, 2002 .

Stent-Mediated Gene Delivery for Site-Specific Transgene Administration to the Airway Epithelium and Management of Tracheobronchial Tumors

R. Levy, I. Fishbein, S. Singhal, 2014, Respiration.

Magnetically targeted delivery of therapeutic agents to injured blood vessels for prevention of in-stent restenosis.

I. Alferiev, I. Fishbein, Richard F. Adamo, 2012, Methodist DeBakey cardiovascular journal.

High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents

Gary Friedman, Robert J Levy, Ilia Fishbein, 2008, Proceedings of the National Academy of Sciences.

Intraprocedural endothelial cell seeding of arterial stents via biotin/avidin targeting mitigates in-stent restenosis

I. Alferiev, R. Levy, S. J. Stachelek, 2022, bioRxiv.

Site‐specific gene delivery to stented arteries using magnetically guided zinc oleate‐based nanoparticles loaded with adenoviral vectors

I. Alferiev, R. Levy, I. Fishbein, 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Formulation and In Vitro Characterization of Composite Biodegradable Magnetic Nanoparticles for Magnetically Guided Cell Delivery

I. Alferiev, R. Levy, I. Fishbein, 2012, Pharmaceutical Research.

Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields

Mansoor Amiji, Srinivas Ganta, Gary Friedman, 2010, Proceedings of the National Academy of Sciences.

Experimental Single-Platform Approach to Enhance the Functionalization of Magnetically Targetable Cells.

I. Alferiev, R. Levy, I. Fishbein, 2020, ACS applied bio materials.

Activated polyurethane modified with latent thiol groups.

I. Alferiev, I. Fishbein, 2002, Biomaterials.

Controlled periadventitial administration of verapamil inhibits neointimal smooth muscle cell proliferation and ameliorates vasomotor abnormalities in experimental vein bypass grafts.

T. Drake, I. Fishbein, G. Golomb, 1997, The Journal of thoracic and cardiovascular surgery.

Systemic Depletion of Macrophages by Liposomal Bisphosphonates Reduces Neointimal Formation Following Balloon-Injury in the Rat Carotid Artery

I. Fishbein, G. Golomb, J. Waltenberger, 2003, Journal of cardiovascular pharmacology.

The incorporation of an ion channel gene mutation associated with the long QT syndrome (Q9E-hMiRP1) in a plasmid vector for site-specific arrhythmia gene therapy: in vitro and in vivo feasibility studies.

R. Levy, I. Fishbein, D. Coulter, 2003, Human gene therapy.

Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization.

Vaishali V. Inamdar, I. Alferiev, R. Levy, 2020, Journal of visualized experiments : JoVE.

Robust Chemical Strategy for Stably Labeling Polyester-Based Nanoparticles with BODIPY Fluorophores.

I. Alferiev, R. Levy, I. Fishbein, 2022, ACS applied polymer materials.

Enhanced biocompatibility of CD47-functionalized vascular stents.

I. Alferiev, J. Weisel, R. Levy, 2016, Biomaterials.

Vascular gene transfer from metallic stent surfaces using adenoviral vectors tethered through hydrolysable cross-linkers.

I. Alferiev, R. Levy, I. Fishbein, 2014, Journal of visualized experiments : JoVE.

Inhibition of aortic allograft vasculopathy by local delivery of platelet-derived growth factor receptor tyrosine-kinase blocker AG-12951

I. Fishbein, G. Golomb, A. Levitzki, 2002, Transplantation.

Optimizing endothelial cell functionalization for cell therapy of vascular proliferative disease using a direct contact co-culture system

I. Alferiev, R. Levy, I. Fishbein, 2018, Drug Delivery and Translational Research.

Nanomedicines for Restenosis Therapy

R. Levy, I. Fishbein, M. Chorny, 2014 .

Magnetic nanoparticles for targeted vascular delivery

Ivan S. Alferiev, Michael Chorny, Ilia Fishbein, 2011, IUBMB life.

Biodegradable Nanoparticles as Drug Delivery Systems for Parenteral Administration

Ilia Fishbein, I. Fishbein, G. Golomb, 2003 .

Site-specific gene therapy for cardiovascular disease.

R. Levy, I. Fishbein, M. Chorny, 2010, Current opinion in drug discovery & development.

Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics.

Ilia Fishbein, I. Fishbein, G. Golomb, 2002, Journal of controlled release : official journal of the Controlled Release Society.

Study of the drug release mechanism from tyrphostin AG-1295-loaded nanospheres by in situ and external sink methods.

Ilia Fishbein, I. Fishbein, G. Golomb, 2002, Journal of controlled release : official journal of the Controlled Release Society.

Adenoviral vector tethering to metal surfaces via hydrolyzable cross-linkers for the modulation of vector release and transduction.

I. Alferiev, R. Levy, I. Fishbein, 2013, Biomaterials.

Magnetically enhanced cell delivery for accelerating recovery of the endothelium in injured arteries.

I. Alferiev, R. Levy, I. Fishbein, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Site Specific Controlled Release for Cardiovascular Disease: Translational Directions

I. Alferiev, R. Levy, I. Fishbein, 2012 .

Stent-based delivery of adeno-associated viral vectors with sustained vascular transduction and iNOS-mediated inhibition of in-stent restenosis

I. Alferiev, R. Levy, I. Fishbein, 2017, Gene Therapy.

Controlled delivery of a tyrphostin inhibits intimal hyperplasia in a rat carotid artery injury model.

I. Fishbein, G. Golomb, A. Levitzki, 1996, Atherosclerosis.

Biodegradable implant strategies for inhibition of restenosis

I. Fishbein, G. Golomb, A. Domb, 1997 .

Modulation of NO and ROS production by AdiNOS transduced vascular cells through supplementation with L-Arg and BH4: implications for gene therapy of restenosis.

I. Alferiev, R. Levy, I. Fishbein, 2013, Atherosclerosis.

Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma Models

I. Alferiev, I. Fishbein, G. Brodeur, 2022, International journal of molecular sciences.

Nanoparticle-mediated delivery of a rapidly activatable prodrug of SN-38 for neuroblastoma therapy.

I. Alferiev, R. Levy, I. Fishbein, 2015, Biomaterials.

Site specific gene delivery in the cardiovascular system.

I. Alferiev, R. Levy, S. J. Stachelek, 2005, Journal of controlled release : official journal of the Controlled Release Society.

Formulation and Delivery Mode Affect Disposition and Activity of Tyrphostin-Loaded Nanoparticles in the Rat Carotid Model

I. Fishbein, G. Golomb, A. Levitzki, 2001, Arteriosclerosis, thrombosis, and vascular biology.

Tyrphostins, inhibitors of protein tyrosine kinase, in restenosis

I. Fishbein, G. Golomb, 1997 .

Hypercholesterolemia aggravates in-stent restenosis in rabbits: a mitigating effect of stent surface modification with CD47-derived peptide

Vaishali V. Inamdar, I. Alferiev, R. Levy, 2023, bioRxiv.

Stability and bioactivity of pepCD47 attachment on stainless steel surfaces.

Vaishali V. Inamdar, I. Alferiev, R. Levy, 2020, Acta biomaterialia.

Paraffin processing of stented arteries using a postfixation dissolution of metallic and polymeric stents.

I. Alferiev, R. Levy, I. Fishbein, 2016, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Local Delivery of Gene Vectors From Bare-Metal Stents by Use of a Biodegradable Synthetic Complex Inhibits In-Stent Restenosis in Rat Carotid Arteries

I. Alferiev, R. Levy, S. J. Stachelek, 2008, Circulation.

PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine.

I. Fishbein, G. Golomb, L. Rabinovich, 1998, Circulation.

Treatment of restenosis by controlled‐release delivery systems of tyrphostins

I. Fishbein, G. Golomb, M. Chorny, 2000 .

Adenoviral gene vector tethering to nanoparticle surfaces results in receptor-independent cell entry and increased transgene expression.

Robert J Levy, Ilia Fishbein, I. Alferiev, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Magnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells.

Robert J Levy, Ilia Fishbein, I. Alferiev, 2009, Molecular pharmaceutics.

Local delivery of platelet-derived growth factor receptor-specific tyrphostin inhibits neointimal formation in rats.

I. Fishbein, G. Golomb, L. Rabinovich, 2000, Arteriosclerosis, thrombosis, and vascular biology.

Gene Delivery from Stents for Prevention of In-Stent Restenosis

I. Alferiev, R. Levy, I. Fishbein, 2016, European Medical Journal.

Endovascular Gene Delivery from a Stent Platform: Gene- Eluting Stents

I. Alferiev, R. Levy, I. Fishbein, 2013, Angiology: open access.

Analytical chemistry: The matrix neutralized

R. Levy, I. Fishbein, 2009, Nature.

Site-specific delivery of colchicine in rat carotid artery model of restenosis

I. Fishbein, G. Golomb, D. Mishaly, 1997 .

Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries.

Alexander Levitzki, Ilia Fishbein, I. Fishbein, 2005, Biomaterials.

Stent-based delivery of AAV2 vectors encoding oxidation-resistant apoA1

I. Alferiev, R. Levy, R. Gorman, 2022, Scientific Reports.

Optimizing endothelial cell functionalization for cell therapy of vascular proliferative disease using a direct contact co-culture system

I. Alferiev, R. Levy, I. Fishbein, 2018, Drug Delivery and Translational Research.

Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis.

I. Fishbein, G. Golomb, L. Rabinovich, 2000, Journal of controlled release : official journal of the Controlled Release Society.

Local delivery of mithramycin restores vascular reactivity and inhibits neointimal formation in injured arteries and vascular grafts.

I. Fishbein, G. Golomb, H. Laks, 2001, Journal of controlled release : official journal of the Controlled Release Society.

Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents.

I. Alferiev, R. Levy, I. Fishbein, 2006, Proceedings of the National Academy of Sciences of the United States of America.